Indian officials are looking into possible safety violations in the supply of a pharmaceutical ingredient that may have led to the contamination of cough syrup, resulting in the deaths of 24 children. The investigation has uncovered flaws in global safety practices and led to the revocation of a manufacturing license and the arrest of the company’s founder.